Centre Hospitalier Universitaire de Liège

Futó vizsgálatok

• Még nem toboroz

  A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis

  NCT07335562· 3. fázis· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Forrás

• Még nem toboroz

  Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

  NCT07441408· 3. fázis· Bristol-Myers Squibb· Forrás

• Még nem toboroz

  A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies

  NCT07789015· 3. fázis· Boehringer Ingelheim· Forrás

• Még nem toboroz

  A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment

  NCT07926321· 2. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Mi2000 TICI - Post-market Implantation Study

  NCT07897318· MED-EL Elektromedizinische Geräte GmbH· Forrás

• Toboroz

  Mi2000 TICI Follow-up

  NCT07902414· MED-EL Elektromedizinische Geräte GmbH· Forrás

• Toboroz

  A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants with Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  2024-518365-10-00· 3. fázis· F. Hoffmann-La Roche AG· Forrás

• Még nem toboroz

  A pivotal clinical study to investigate the safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis due to Metabolic dysfunction-associated steatohepatitis (MASH)

  2026-525755-82-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Még nem toboroz

  A study to investigate safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis (stage F4 fibrosis) due to MASH (NEBULA-2)

  2026-525757-37-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Toboroz

  Phase 3 Study of Investigator Choice of Chemotherapy with or without Zoldonrasib as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma

  2025-524928-21-00· 3. fázis· Revolution Medicines Inc.· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

  NCT07541170· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

  NCT07648264· 3. fázis· CSL Behring· Forrás

• Toboroz

  A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

  NCT07623200· 3. fázis· Incyte Corporation· Forrás

• Toboroz

  A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)

  2025-525009-18-00· 3. fázis· Incyte Corp.· Forrás

• Még nem toboroz

  Phase 2 Trial of TAK-755 for Acute Ischemic Stroke

  2025-522734-31-00· 2. fázis· Takeda Development Center Americas Inc.· Forrás

• Toboroz

  A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax (ABBV-453) Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

  2025-525105-20-00· 1/2. fázis· AbbVie Deutschland GmbH & Co. KG· Forrás

• Toboroz

  A clinical trial to learn about the long-term safety of FUB523 (zigakibart) in people with immunoglobulin A (IgA) nephropathy who have completed previous zigakibart trials

  2024-519638-22-00· 3. fázis· Novartis Pharma AG· Forrás

• Még nem toboroz

  Phase II study of ezabenlimab in patients with PD-L1-positive head and neck cancer with residual disease detected by ctDNA after chemoradiotherapy

  2025-523575-36-00· 2. fázis· Cliniques Universitaires Saint-Luc· Forrás

• Toboroz

  A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer

  NCT07673887· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Toboroz

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis

  NCT07725939· 2. fázis· UCB Biopharma SRL· Forrás

• Toboroz

  A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

  NCT07659782· 2. fázis· Verastem, Inc.· Forrás

• Toboroz

  An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

  NCT07665437· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

  NCT07544654· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

  NCT07516951· 2. fázis· Chiesi Farmaceutici S.p.A.· Forrás

• Toboroz

  A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

  NCT07690371· 3. fázis· Nektar Therapeutics· Forrás

• Toboroz

  Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

  NCT07284602· 3. fázis· PureTech· Forrás

• Toboroz

  A Study to Test How Well ZL-1310 may Work Compared to Therapies Selected by the Investigator in Treating Patients with Relapsed Small Cell Lung Cancer

  2025-522818-23-00· 3. fázis· Zai Lab (US) LLC· Forrás

• Toboroz

  Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year

  2025-521590-13-00· 3. fázis· Janssen Cilag International· Forrás

• Toboroz

  Is local injection of mesenchymal stem cells after endoscopic dilation safe and does it improve the outcome of intestinal stricture in patients with Crohn's disease?

  NCT06317818· 2. fázis· Centre hospitalier universitaire de Liege· Forrás

• Toboroz

  First Clinical Study to Evaluate Safety, Tolerability & PK of DX243 in Healthy Volunteers and Patients With Hearing Loss

  NCT07637981· 2. fázis· Dendrogenix· Forrás

• Toboroz

  A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

  NCT07365995· 3. fázis· BioNTech SE· Forrás

• Toboroz

  A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT07499232· 3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss

  NCT07503210· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo

  NCT07533019· 2. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Endometrial Cancer ( RAINFOL-03 )

  2024-519818-31-01· 3. fázis· Genmab A/S· Forrás

• Toboroz

  Radiopharmaceutical Treatment of Advanced Kidney Cancer

  NCT06783348· 2. fázis· European Organisation for Research and Treatment of Cancer - EORTC· Forrás

• Toboroz

  Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy

  NCT07225270· 3. fázis· Genmab· Forrás

• Toboroz

  Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer

  NCT07736937· 1/2. fázis· Gilead Sciences· Forrás

• Toboroz

  A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  NCT07351045· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma

  NCT07456033· 3. fázis· GlaxoSmithKline· Forrás

• Toboroz

  Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

  NCT07286058· 3. fázis· Takeda· Forrás

• Toboroz

  Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  NCT07491445· 3. fázis· Revolution Medicines, Inc.· Forrás

• Toboroz

  Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

  NCT07223814· 3. fázis· Stichting Hemato-Oncologie voor Volwassenen Nederland· Forrás

• Toboroz

  Clinical Performance and Safety Assessment of the Use of iCover Balloon Expandable Covered Stent (iVascular) Implanted as Bridging Stent in FEVAR (Fenestrated Endovascular Aortic Repair) for the Treatment of Complex Abdominal Aortic Aneurysms

  NCT07529275· iVascular S.L.U.· Forrás

• Toboroz

  A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

  NCT07222332· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

  NCT07288177· 2. fázis· Genmab· Forrás

• Toboroz

  A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

  NCT07216703· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

  NCT07195695· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Effect of IMT in Patients After Acute Exacerbations of COPD

  NCT07213128· KU Leuven· Forrás

Showing 50 of 310.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák23 toboroz
• Crohn-betegség14 toboroz
• Méhtestrák8 toboroz
• Mielóma multiplex8 toboroz
• Petefészekrák8 toboroz
• Gyomor- és nyelőcsőrák7 toboroz
• Hasnyálmirigyrák6 toboroz
• Idiopátiás tüdőfibrózis6 toboroz
• Máj- és epeúti rák6 toboroz
• Vastagbélrák6 toboroz
• Akut mieloid leukémia (AML)5 toboroz
• Colitis ulcerosa5 toboroz
• Lupus (SLE)5 toboroz
• Pikkelysömör5 toboroz
• Prosztatarák5 toboroz
• Zsírmáj (MASLD/MASH)5 toboroz
• Áttétes emlőrák4 toboroz
• Fej-nyaki daganatok4 toboroz
• Stroke (szélütés)4 toboroz
• Arthritis psoriatica3 toboroz
• Asztma3 toboroz
• Gyermekkori daganatok3 toboroz
• Hearing loss3 toboroz
• Hidradenitis suppurativa3 toboroz
• Hólyagrák3 toboroz
• Krónikus limfoid leukémia (CLL)3 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)3 toboroz
• Méhnyakrák3 toboroz
• Melanóma3 toboroz
• Mieloproliferatív neopláziák3 toboroz
• Rheumatoid arthritis3 toboroz
• Szisztémás szklerózis (szkleroderma)3 toboroz
• Tripla negatív emlőrák3 toboroz
• 2-es típusú cukorbetegség2 toboroz
• Akut limfoid leukémia (ALL)2 toboroz
• Elhízás2 toboroz
• Glioblasztóma2 toboroz
• Köpenysejtes limfóma2 toboroz
• Liver cirrhosis2 toboroz
• Neuroendokrin daganatok2 toboroz
• Vesedaganat2 toboroz
• Vitiligo2 toboroz
• 1-es típusú cukorbetegség1 toboroz
• Alzheimer-kór1 toboroz
• Amiloidózis1 toboroz
• Aortic aneurysm1 toboroz
• Atópiás dermatitisz (ekcéma)1 toboroz
• Bronchiectasis1 toboroz
• Cytomegalovirus infection1 toboroz
• Dermatomyositis and polymyositis (myositis)1 toboroz
• Hodgkin-limfóma1 toboroz
• IgA-nefropátia1 toboroz
• Irritable bowel syndrome1 toboroz
• Krónikus mieloid leukémia (CML)1 toboroz
• Mielodiszplasztikus szindróma (MDS)1 toboroz
• Parkinson-kór1 toboroz
• Primer biliáris cholangitis (PBC)1 toboroz
• Spondylitis ankylopoetica (Bechterew-kór)1 toboroz
• Szarkóma1 toboroz

Lezárt vizsgálatok

• Leállították

  HER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients With Advanced HER2-positive Breast Cancer

  NCT06595563· 2. fázis· Jules Bordet Institute· Forrás

• Lezárult

  Evaluation of the CochSyn Device in Clinical Practice

  NCT07091071· University Ghent· Forrás

• Visszavonták

  Knee OsteoArthritis Long-term Assessment

  NCT06839222· Allegro NV/SA· Forrás

• Lezárult

  A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Belgium

  NCT06677892· Takeda· Forrás

• Fut, nem toboroz

  Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)

  NCT06632951· 2. fázis· AbbVie· Forrás

• Fut, nem toboroz

  Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis

  NCT06846541· 3. fázis· Alumis Inc· Forrás

• Lezárult

  Smart MDI Study (CIP343)

  NCT06645834· Medtronic MiniMed, Inc.· Forrás

• Lezárult

  Acceptability of Artificial Intelligence in the Diagnosis of Prostate Cancer

  NCT07074405· Centre Hospitalier Universitaire de Liege· Forrás

• Lezárult

  Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)

  NCT06433219· 2. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Lezárult

  A study to evaluate the efficacy and safety of subcutaneous sonelokimab compared with placebo in adult participants with moderate to severe hidradenitis suppurativa

  2024-511363-28-00· 3. fázis· MoonLake Immunotherapeutics AG· Forrás

• Lezárult

  A study to test whether BI 1839100 improves cough in people with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis

  2023-510249-79-00· 2. fázis· Boehringer Ingelheim International GmbH· Forrás

• Lezárult

  A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT06335303· 2. fázis· Boehringer Ingelheim· Forrás

• Fut, nem toboroz

  Phase IIa Study Evaluating AZD7798 in Crohn's Disease

  NCT06450197· 2. fázis· AstraZeneca· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis

  NCT06586112· 3. fázis· Alumis Inc· Forrás

• Lezárult

  A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the treatment of idiopathic pulmonary fibrosis (BEACON-IPF)

  2023-506185-31-00· 2/3. fázis· Pliant Therapeutics Inc.· Forrás

• Toboroz

  Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

  NCT06324357· 1/2. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  A study evaluating the safety and efficacy of GLPG5101 (19CP02) in subjects with non-Hodgkin lymphoma

  NCT06561425· 1/2. fázis· Lakefront Biotherapeutics· Forrás

• Lezárult

  Mi2000 Totally Implantable Cochlear Implant (Mi2000 TICI)

  NCT06459765· MED-EL Elektromedizinische Geräte GmbH· Forrás

• Lezárult

  A study to investigate the efficacy and safety of luveltamab tazevibulin versus IC chemotherapy in women with ovarian cancer (including fallopian tube or primary peritoneal cancers) expressing FOLR1

  NCT05870748· 2. fázis· Sutro Biopharma Inc.· Forrás

• Fut, nem toboroz

  ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer

  NCT06328738· 1. fázis· Enliven Therapeutics· Forrás

• Leállították

  A Study to Test Long-term Treatment With Spesolimab in People With a Skin Condition Disease Called Hidradenitis Suppurativa (HS) Who Took Part in a Previous Study With Spesolimab

  NCT06241573· 2/3. fázis· Boehringer Ingelheim· Forrás

• Visszavonták

  First-In-Human (FIH), Single Ascending Dose (SAD) Study of FluoroEthylNorMemantine (FENM)

  NCT05921929· 1. fázis· ReST Therapeutics· Forrás

• Lezárult

  A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis

  2023-504564-42-00· 2. fázis· Anaptysbio Inc.· Forrás

• Fut, nem toboroz

  A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis

  NCT06257875· 2. fázis· AbbVie· Forrás

• Lezárult

  A Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of Selnoflast in Participants with Moderate to Severe Asthma

  2023-504304-29-00· 1. fázis· F. Hoffmann-La Roche AG· Forrás

• Lezárult

  GEN1046 in Combination With Anticancer Agents for the Treatment of Advanced Endometrial Cancer

  2022-502453-33-00· 2. fázis· Genmab A/S· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa

  NCT06212999· 3. fázis· Incyte Corporation· Forrás

• Fut, nem toboroz

  A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

  NCT06105632· 2. fázis· Pfizer· Forrás

• Fut, nem toboroz

  MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

  NCT06132256· 2. fázis· Syndax Pharmaceuticals· Forrás

• Lezárult

  A study evaluating the safety, tolerability, and efficacy of GLPG5101 in adults with treatment-refractory active systemic lupus erythematosus

  2023-504422-19-00· 1. fázis· Galapagos· Forrás

• Lezárult

  A 14-week Pilot Prospective Clinical Trial With BiOkuris Product in Patients With Irritable Bowel Syndrome

  NCT05780749· Biokuris s.a.· Forrás

• Lezárult

  A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension

  NCT06034743· 3. fázis· AstraZeneca· Forrás

• Lezárult

  A phase I/II open label, multicenter study evaluating the feasibility, safety and efficacy of point-of-care manufactured antiBCMA CAR T cells (GLPG5301; BCMACP03) in subjects with relapsed/refractory Multiple Myeloma (RRMM)

  2022-500782-27-00· 1/2. fázis· Lakefront Biotherapeutics· Forrás

• Lezárult

  Quality-of-Life Index (Q-Index)

  NCT06209502· Koios Care· Forrás

• Lezárult

  A Phase 3, Double-blind Maintenance Study Assessing Rocatinlimab in Moderate-to-severe AD (ROCKET-ASCEND)

  NCT05882877· 3. fázis· Amgen Inc.· Forrás

• Lezárult

  A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT06049017· 2. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

  NCT05848011· 2. fázis· MacroGenics· Forrás

• Lezárult

  TRansmural hEaliNg Definition in CroHn's Disease (TRENCH 1)

  NCT05903066· Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives· Forrás

• Lezárult

  Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)

  NCT05882734· 1/2. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Lezárult

  A study to investigate response to ompenaclid combined with FOLFIRI plus bevacizumab in patients with advanced or metastatic colorectal cancer

  2023-503356-27-00· 2. fázis· Inspirna Inc.· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Vixarelimab Compared with Placebo in Patients with Idiopathic Pulmonary Fibrosis and in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease

  2022-502828-42-00· 2. fázis· Genentech Inc.· Forrás

• Lezárult

  Long-term Safety and Efficacy of Efavaleukin Alfa in Subjects With Moderately to Severely Active Ulcerative Colitis

  NCT05672199· 2. fázis· Amgen Inc.· Forrás

• Lezárult

  Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

  NCT05814627· 3. fázis· AbbVie· Forrás

• Lezárult

  Safety and Tolerability of CVGBM in Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma

  NCT05938387· 1. fázis· CureVac· Forrás

• Lezárult

  A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis

  NCT05507580· 4. fázis· AbbVie· Forrás

• Lezárult

  A Study of Two Dose Levels of Vobramitamab Duocarmazine in Participants with Metastatic Castration-resistant Prostate Cancer (TAMARACK)

  NCT05551117· 2. fázis· Macrogenics Inc.· Forrás

• Lezárult

  Phase 3, 52-week Study Evaluating Rocatinlimab (AMG451)in Adolescent Subjects With Moderate-to-severe AD (ROCKET-ASTRO)

  2022-501586-50-00· 3. fázis· Amgen Inc.· Forrás

• Lezárult

  A study to see how well CVGBM vaccine works at different doses and how safe it is in patients who had surgery for glioblastoma or astrocytoma

  2022-501423-25-00· 1/2. fázis· Curevac AG· Forrás

• Lezárult

  A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

  NCT05704738· 3. fázis· Amgen· Forrás

• Lezárult

  Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

  NCT05819398· 2/3. fázis· Boehringer Ingelheim· Forrás

Showing 50 of 149.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Crohn-betegség40 munka · 28 vizsgálat
• Colitis ulcerosa25 munka · 17 vizsgálat
• Spinális izomatrófia (SMA)8 munka · 0 vizsgálat